Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KMT2A | Q03164 | 1/20 | 0.82 |
| ▸ | PLA2G4B | P0C869 | 3/20 | 0.82 |
| ▸ | SMPD1 | P17405 | 3/20 | 0.74 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.73 |
| ▸ | NR1H4 | Q96RI1 | 2/20 | 0.73 |
| ▸ | TP53 | P04637 | 1/20 | 0.69 |
| ▸ | TSHR | P16473 | 1/20 | 0.69 |
| ▸ | PTPN11 | Q06124 | 1/20 | 0.67 |
| ▸ | THRA | P10827 | 1/20 | 0.67 |
| ▸ | THRB | P10828 | 1/20 | 0.67 |
| ▸ | RARB | P10826 | 3/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31661137 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL4652291 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL15766225 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL7822821 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL8081150 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL7047692 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL8082044 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL8086388 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL2887568 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 | |
| SCHEMBL29758526 | 1.00 | KMT2A (0.82) | KMT2APLA2G4BSMPD1PLA2G2ANR1H4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2016058991-A1 | POLYMERS FEATURING ENHANCED FLOW | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2016-04-21 | — | — | WO | claimed |
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2023-06-29 | — | — | US | disclosed |
| WO-2016058991-A1 | POLYMERS FEATURING ENHANCED FLOW | SOLVAY SPECIALTY POLYMERS USA, LLC (US) | 2016-04-21 | — | — | WO | disclosed |
| CN-104981452-A | Skin whitening agent containing novel cyclic compound | RNS CO LTD | 2015-10-14 | — | — | CN | disclosed |
| US-8501037-B2 | Optically anisotropic compound and resin composition comprising the same | LG CHEM, LTD. (KR) | 2013-08-06 | — | — | US | disclosed |
| US-8501037-B2 | Optically anisotropic compound and resin composition comprising the same | LG CHEM, LTD. (KR) | 2013-08-06 | — | — | US | disclosed |
| US-20100130659-A1 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2010-05-27 | — | — | US | disclosed |
| US-20100130659-A1 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2010-05-27 | — | — | US | disclosed |
| WO-2009025484-A2 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | LG CHEM, LTD. (KR) | 2009-02-26 | — | — | WO | disclosed |
| EP-0758013-B1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL CO LTD (JP) | 2000-10-11 | — | — | EP | disclosed |
| US-5855971-A | Liquid crystalline optical film, compensating film for liquid crystal display comprising the liquid crystalline optical film, and liquid crystal display having the compensating film | NIPPON OIL COMPANY, LIMITED (JP) | 1999-01-05 | — | — | US | disclosed |
| WO-1998043649-A2 | AGE PRODUCTION INHIBITORY COMPOSITION COMPRISING A MAILLARD REACTION INHIBITOR AND VITAMIN B¿6? | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1998-10-08 | — | — | WO | disclosed |
| EP-0758013-A1 | Liquid crystalline optical film, compensating film for liquid crystal display and liquid crystal display | NIPPON OIL COMPANY, LIMITED (JP) | 1997-02-12 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230205083-A1 | SALT COMPOUND, RESIST COMPOSITION AND PATTERNING PROCESS | SLC6A9, SLC6A5, REN | KMT2A 2175/4885PLA2G4B 2926/4885SMPD1 2729/4885 |
| US-20100130659-A1 | OPTICALLY ANISOTROPIC COMPOUND AND RESIN COMPOSITION COMPRISING THE SAME | RCC1, RER1, MED1 | KMT2A 1007/4885PLA2G4B 1904/4885SMPD1 3734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.